Molecular Partners AG -ADRMOLN
13F holders, Q2 2024 (June 30)8holders
1new positions
1sold out
$7.19avg. 13F price*
At the end of Q2 2024, 8 institutions reported holding Molecular Partners AG -ADR (MOLN) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were BVF Inc. ($3.2M), Montanova Capital, LLC ($2.9M) and Old Mission Capital LLC ($75K).
- Company
- Molecular Partners AG -ADR
- CUSIP
- 60853G106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $75K |
| Exits | 1 | $6K |
All 13F filers, Q1 2024 → Q2 2024: 13,500 shares bought and 99,000 shares sold, net −85,500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| BVF Inc. | 0.09% | No change | 443,221 | $3.2M |
| Montanova Capital, LLC | 0.12% | No change | 400,000 | $2.9M |
| Old Mission Capital LLC | 0.00% | New | 10,365 | $75K |
| UBS Group AG | 0.00% | Add +961.7% | 3,461 | $25K |
| Tang Capital Management LLC | 0.00% | Reduce -97.5% | 2,500 | $18K |
| Morgan Stanley | 0.00% | No change | 367 | $3K |
| Rhumbline Advisers | 0.00% | No change | 269 | $2K |
| Qube Research & Technologies Ltd | 0.00% | No change | 16 | $114 |
"% of holder's portfolio" is MOLN's weight in each manager's 13F, not the share of Molecular Partners AG -ADR the manager owns.